17/04/2020
According to Dr. Kathleen Mullan, a specialist in infectious diseases at the University of Chicago, most of the patients who participated in the clinical trials of the new drug have already been discharged.
The test involved those people with COVID-19 who showed severe respiratory symptoms and fever. It is reported that such treatment took less than a week, and, according to scientists, the duration of such therapy should not be more than 10 days.